Novel PNPLA2 gene mutation in a child causing neutral lipid storage disease with myopathy

Shouyan Zheng,Wei Liao
DOI: https://doi.org/10.1186/s12881-018-0683-9
2018-09-17
BMC Medical Genetics
Abstract:BackgroundPNPLA2 gene mutations cause neutral lipid storage disease with myopathy (NLSD-M) or cardiomyopathies. The clinical phenotype, blood test results, imaging examination and gene analysis can be used to improve the understanding of NLSD-M, reduce the misdiagnosis rate and prevent physical disability and even premature death.Case presentationWe report a Chinese child with NLSD-M presenting with marked asymmetric skeletal myopathy and hypertrophic cardiomyopathy. Blood biochemical tests revealed increased creatine kinase levels, and echocardiography revealed a diffuse and thick left ventricular wall. Gene analysis revealed a homozygous mutation c.155C > G (p.Thr52Arg) in PNPLA2.ConclusionsAn understanding of the characteristic features is essential for the early diagnosis of NLSD-M. Our data expand the allelic spectrum of PNPLA2 mutations, providing further evidence for genetic and clinical NLSD-M heterogeneity in younger individuals.
genetics & heredity
What problem does this paper attempt to address?